Nobilis Health Corp.

Nobilis Health Corp.

NRTSF
Nobilis Health Corp.US flagOther OTC
0.00
USD
- -
- -
78.00Market Cap
2003 Y
2004 Y
2007 Y
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
TTM
Revenue per Share
0.12
0.11
2.39
3.08
1.79
0.66
0.43
0.59
0.85
1.81
3.42
3.74
3.85
3.65
Basic EPS, GAAP
-0.22
-0.1
-0.51
-7.5
-0.75
-0.26
-0.07
0.03
0.04
0.14
0.76
0.08
0.05
0.02
Free Cash Flow per Basic Share
-0.06
-0.09
1.31
1.56
0.65
-0.22
-0.01
0.13
0.06
0.04
0.03
-0.05
0.27
0.1
Dividend per Share
- -
- -
0.6
0.99
0.05
- -
0.04
0.08
0.12
- -
- -
- -
- -
- -
Book Value per Share
-0.2
-0.24
-0.51
-8.99
-9.74
-7.46
-4.27
-3.98
-3.8
-2.86
-1.28
-1.03
-0.97
-1
Tangible Book Value per Share
-0.12
-0.13
-0.47
0.37
0.58
0.4
0.11
0.19
0.37
0.5
1.04
0.79
0.2
0.14
Basic Weighted Avg Shares
31
36
14
14
14
19
33
35
37
47
67
76
78
78
Sales/Revenue/Turnover
4
4
33
43
25
12
14
21
31
84
229
286
300
285
Operating Margin (%)
-177.11
-75.46
64.77
39.24
9.5
-55.63
13.95
25.76
14.45
24.22
15.36
3.38
8.24
8.02
Depreciation Expense
- -
- -
1
2
1
1
1
1
1
2
5
9
12
16
Net Income, GAAP
-7
-4
3
-104
-10
-5
-2
1
1
7
51
6
4
2
Effective Tax Rate (%)
- -
- -
28.12
- -
- -
- -
- -
- -
- -
- -
- -
38.72
55.84
60.7
Profit Margin (%)
-192.47
-93.59
9.6
-243.59
-41.67
-40.36
-15.13
5.74
4.55
8
22.18
2.26
1.27
0.58
Working Capital
-4
-5
15
10
8
5
4
7
9
24
64
98
98
97
LT Debt
- -
1
- -
- -
- -
- -
- -
2
- -
11
38
78
126
127
Total Equity
-4
-5
142
22
10
9
6
9
16
65
134
142
198
190
Return on Invested Capital (%)
- -
- -
22.21
- -
- -
- -
- -
69.37
34.7
40.19
- -
2.97
3.92
3.2
Return on Capital (%)
- -
- -
151.06
- -
- -
- -
- -
2.08
3.03
5.61
- -
-56.26
-0.06
-1.42
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Dec'17
Mar'18
Jun'18
ST Debt
11
14
13
LT Borrowings
113
115
116
LT Finance Leases
13
12
11
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
78
78
78
Market Capitalization
105
129
94

Working Capital

FRC

•

in mil. unless spec.
Dec'17
Mar'18
Jun'18
Total Current Assets
185
175
178
Cash, Cash Equivalents & STI
23
23
17
Accounts Receivable, Net
145
133
144
Inventories
3
3
3
Total Current Liabilities
87
80
80
Payables & Accruals
65
54
55
ST Debt
11
14
13
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
40.45%
106.77%
39%
Free Cash Flow
-360.2%
-189.76%
-633.35%
Net Income, GAAP
-283.06%
184.16%
-41.12%
Sales/Revenue/Turnover
42.09%
84.25%
4.89%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2016
51
62
71
102
286
2017
68
80
65
87
300
2018
64
69
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2016
-0.07
0.06
-0.04
0.12
0.08
2017
-0.03
0.02
0.01
0.05
0.05
2018
-0.05
0.01
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2016
- -
- -
- -
- -
- -
2017
- -
- -
- -
- -
- -
2018
- -
- -
- -
- -
- -

Company Description

CEO
Patrick Yoder
Full Time Employees
700
Sector
Healthcare
Industry
Medical - Care Facilities
Address
Houston Canada
IPO Date
Nov 7, 2011
Business
Nobilis Health Corp. (NRTSF) operates as a healthcare services company focused on providing surgical and ancillary medical services through a network of ambulatory surgery centers and specialty clinics. The company offers a range of core products and services including outpatient surgical procedures in areas such as orthopedics, pain management, gastroenterology, and plastic surgery; ancillary services encompassing anesthesia, imaging diagnostics, and physical therapy; and patient financing options to support elective procedures. It primarily serves patients seeking non-emergency ambulatory care, targeting markets in the United States with operations concentrated in Texas and surrounding regions; founded in 2014 and headquartered in Vancouver, Canada, with key facilities managed through subsidiaries. In recent developments within the last two years, Nobilis Health underwent significant operational restructuring including a shift from aggressive clinic expansion to cost optimization and facility rationalization following financial challenges; it also navigated creditor protection proceedings in 2020 leading to substantial debt reduction and equity recapitalization, enabling a stabilized platform for growth; no major new partnerships, acquisitions, or product launches were reported in 2024-2025.